This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

5 Nov 2012

Baxter announces 20-yr partnership with Hemobras in Brazil

Baxter will be the exclusive provider of recombinant factor VIII for the treatment of patients with haemophilia A in Brazil over the coming years.


Healthcare company Baxter has announced a long-term partnership with Brazilian company Hemobras to improve patients' access to the haemophilia A therapy recombinant factor VIII.

Related News